Clinical Trial

Venetoclax for Prevention of Differentiation Syndrom in Acute Promyelocytic Leukemia Patients

Study acronym: Ven APL
Enrolling by Invitation Phase 2/3
View on ClinicalTrials.gov →
Record status
This record was last updated August 9, 2024 (before its estimated August 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study is to assess the efficacy and safety of venetoclax for prevention of DS in APL patients undergoing ATRA/ATO induction regimen.
Trial Details
NCT Number NCT06544109
Lead Sponsor The First Affiliated Hospital of Soochow University
Conditions Acute Promyelocytic Leukemia
Enrollment 98 participants
Start Date 2023-08-01
Primary Completion 2025-08-01 (estimated)
Study Completion 2028-08-01 (estimated)
Updated on ClinicalTrials.gov 2024-08-09